Bioinformatics, Computational Biology, and Multi-Omics–Driven Probiotic Design for Gut Microbiome Engineering

Dr. Mojgani is a Professor of Microbiology at the Razi Vaccine and Serum Research Institute (RVSRI) in Iran. Her research and teaching focus on infectious disease and on the use of probiotic microorganisms and their metabolites in disease prevention and management in humans and animals. She has authored and contributed to scientific books and peer-reviewed publications and participates in ongoing international dissemination through academic conferences. Dr Mojgani also works with industry and non-profit organizations as a senior advisor and consultant, supporting development and translation of probiotic and postbiotic products for veterinary, food, and pharmaceutical applications. She contributes to national standard-setting and regulatory-related activities in Iran and leads professional networks related to probiotics. Her work has been recognized through institutional and national awards.

Dr. Sumel Ashique has been working as an assistant professor at the Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, West Bengal, India. He has 5 years of teaching experience. He has achieved 100+ publications in international and national accredited reputed journals. He has expertise in drug delivery, nanotechnology, and targeted treatment strategies. Recently, he was honored to be in the World’s Top 2% Scientists by prestigious Stanford University, CA, United States, and Elsevier in 2025.

Prof. Wojciech Marlicz is a consultant in gastroenterology, internal medicine, and gastrointestinal endoscopy at Pomeranian Medical University in Szczecin, Poland. His clinical work focuses on diagnostic and therapeutic endoscopy and the management of disorders of gut–brain interaction, inflammatory bowel disease, and gastrointestinal malignancies. His research interests centre on innate mucosal immunity and host–microbe interactions, with particular attention to the role of the microbiome in health and disease.

Prof. Marlicz has gained international clinical and research experience at academic institutions in Europe, North America, and Australia. He has published extensively in peer‑reviewed journals on microbiota, probiotics, and emerging technologies in gastroenterology, including AI‑assisted applications. He serves on editorial boards, is actively involved in academic teaching, and contributes to professional societies and global gastroenterology initiatives.